期刊簡介 | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名稱 | Oncogenesis LetPub Score 7.5
50 ratings
Rate
Reputation 8.3 Influence 6.3 Speed 9.3 | ||||||||||||||||||||
期刊簡稱 | ONCOGENESIS | ||||||||||||||||||||
ISSN | 2157-9024 | ||||||||||||||||||||
h-index | 31 | ||||||||||||||||||||
CiteScore |
| ||||||||||||||||||||
自引率 (2023-2024) | 1.70%自引率趨勢 | ||||||||||||||||||||
掲載範囲 |
| ||||||||||||||||||||
官方網站 | http://www.nature.com/oncsis | ||||||||||||||||||||
在線稿件提交 | http://mts-oncsis.nature.com/cgi-bin/main.plex | ||||||||||||||||||||
開放訪問 | Yes | ||||||||||||||||||||
出版商 | Springer Nature | ||||||||||||||||||||
主題領域 | ONCOLOGY | ||||||||||||||||||||
出版國/地區 | UNITED STATES | ||||||||||||||||||||
發行頻率 | |||||||||||||||||||||
創刊年 | 2012 | ||||||||||||||||||||
每年文章數 | 49每年文章數趨勢 | ||||||||||||||||||||
黃金OA百分比 | 100.00% | ||||||||||||||||||||
OA Related Info | APC: Yes( GBP2790; USD3990; EUR3290; ) APC waiver:Check Notes Other charges: No Keywords: apoptosis、cancer metabolism、cellular oncogenes、dna、damage and repair、tumour suppression Useful LinksAims & ScopeAuthor InstructionsEditorial BoardAnonymous peer review | ||||||||||||||||||||
Web of Science 四分位 ( 2023-2024) | WOS Quartile: Q1
| ||||||||||||||||||||
索引 (SCI or SCIE) | Science Citation Index Expanded | ||||||||||||||||||||
鏈接到PubMed Central (PMC) | https://www.ncbi.nlm.nih.gov/nlmcatalog?term=2157-9024%5BISSN%5D | ||||||||||||||||||||
平均審稿時間 * | 來自出版商的數據: 來自作者的數據: 26 Weeks | ||||||||||||||||||||
競爭力 * | 來自作者的數據: | ||||||||||||||||||||
參考鏈接 |
| ||||||||||||||||||||
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。 |
|
|
首頁 上一頁 1 2 3 4 5 6 7 下一頁 末頁 (頁 | |
[Oncogenesis] 的評論 | 撰寫評論 |
作者: 长安清竹 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-09-25 20:26:35 評論於 Reject the submission.(0) 讚! | 长安清竹 |
作者: 风满迎南 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-08-19 11:14:57 評論於 Does "decision made" 8 days after submission mean the article has been sent for review, or does it indicate a rejection?(0) 讚! | 风满迎南 |
作者: 果汁yh 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-05-06 17:12:04 評論於 The decision is made to change "under consideration" to "decision made". When will the email be sent?(0) 讚! | 果汁yh |
作者: 果汁yh 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-05-06 17:09:12 評論於 Under consideration, when will a decision be made and email notification be sent?(0) 讚! | 果汁yh |
作者: 果汁yh 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-05-06 17:08:30 評論於 Under consideration changed to Decision Made, has the rejection email been sent?(0) 讚! | 果汁yh |
作者: 燃木访松 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-03-25 16:30:06 評論於 How is it going now? How long will it take for the decision to be sent for external review?(0) 讚! | 燃木访松 |
作者: 梓婷小仙女 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-02-19 18:30:26 評論於 Do you need cell identification?(0) 讚! | 梓婷小仙女 |
作者: 梓婷小仙女 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-02-19 09:07:48 評論於 From submission to decision-making, it took 2 months, during which a review email was sent. It started as "Under consideration" and ended with "Decision Made", skipping the "Under review" status(0) 讚! | 梓婷小仙女 |
作者: 深渊绮晴 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-01-18 19:10:30 評論於 It is now two o'clock(0) 讚! | 深渊绮晴 |
作者: 梓婷小仙女 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-01-15 09:06:26 評論於 Sure, thank you. I ended up putting the pictures into Word and uploading them(0) 讚! | 梓婷小仙女 |
作者: 长安清竹 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-01-14 13:01:07 評論於 I uploaded the original image in PPT, and QRT does not need the offline file, just upload the original CT value and processing process in the Excel file(0) 讚! | 长安清竹 |
作者: 梓婷小仙女 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-12-28 21:55:18 評論於 Can you tell me how to handle the upload of my raw data, Western images, and compressed files for qPCR? The system cannot convert them to PDF, so it gets stuck and I cannot submit them(0) 讚! | 梓婷小仙女 |
作者: 长安清竹 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-11-25 22:17:54 評論於 I received a reply one month after the second review and on the second day after the third review(0) 讚! | 长安清竹 |
作者: 长安清竹 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-11-25 16:33:10 評論於 Sending an email(0) 讚! | 长安清竹 |
作者: 寂灭嘉荣 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-11-22 16:39:35 評論於 Is there an email notification for sending external review?(0) 讚! | 寂灭嘉荣 |
作者: 寂灭嘉荣 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-11-22 08:41:06 評論於 Hello, may I ask if the decision made has been rejected?(0) 讚! | 寂灭嘉荣 |
作者: 长安清竹 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-11-21 13:27:49 評論於 Review speed: 6.0 | Submission hit rate: 25.0 Emphasis on research direction: Tumor sharing experiences: The journal has high requirements. After being rejected by c e l l r e p o r t s and o n c o g e n e, I switched to o n c o g e n e si s. One month after submission, it was sent for external review. Three months later, I received feedback for revisions. The reviewers liked my work, so I spent two months completing experiments and making revisions. After resubmitting, I received feedback for revisions one month later, requesting changes to the formatting of the bar chart axes. I made the changes and the next day, it was officially accepted. Overall, the journal does not require as much innovation as o n c o g e n e, but it demands high completeness and rigor in argumentation. There is a large workload, but it is still a good journal, worthy of the title of being a first-tier journal in China's Academy of Sciences(0) 讚! | 长安清竹 |
作者: 寂灭嘉荣 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-11-21 10:15:58 評論於 How are things going now?(0) 讚! | 寂灭嘉荣 |
作者: 长安清竹 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-11-09 14:52:03 評論於 It has been 16 days since the second review, and there is still no news. Can those who have submitted their application provide an estimate of how long the second review typically takes?(0) 讚! | 长安清竹 |
作者: 四风艳庆 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-11-02 20:52:45 評論於 Can you share the submission progress? After 14 days under consideration, will it become a decision made? Will it be a rejection or will an email be sent?(0) 讚! | 四风艳庆 |
作者: 长安清竹 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-10-27 17:58:12 評論於 May I know how long it takes to receive news of the final appeal?(0) 讚! | 长安清竹 |
作者: 长安清竹 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-08-25 23:45:08 評論於 Q R T needs the original c t value, and wb needs the original image with a marker(0) 讚! | 长安清竹 |
作者: 长安清竹 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-08-25 16:46:24 評論於 Focused research direction: tumor experience sharing: It has been 4 months since the first review, and still no news, so slow(0) 讚! | 长安清竹 |
作者: 长安清竹 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-05-30 09:36:44 評論於 The editorial department is reviewing the manuscript at a slow pace. It took 10 days to assign reviewers A and E. It will be another 3 weeks before it is sent for external review(0) 讚! | 长安清竹 |
作者: 弹腿惠君 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-05-29 20:27:34 評論於 When preparing the submission, what original data do you need? Thank you(0) 讚! | 弹腿惠君 |
首頁 上一頁 1 2 3 4 5 6 7 下一頁 末頁 (頁 |
Contact us